EDGAR Filing Documents for 0001654954-17-011831

Form 8-K - Current report:

SEC Accession No. 0001654954-17-011831

Filing Date

2017-12-21

Accepted

2017-12-21 17:19:57

Documents

Period of Report

2017-12-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	qtxb8k_dec152017.htm	8-K	40526
2	ASSET PURCHASE AGREEMENT, DATED DECEMBER 14, 2017	ex10-1.htm	EX-10.1	214090
3	PATENT ASSIGNMENT, DATED DECEMBER 14, 2017	ex10-2.htm	EX-10.2	32412
4	TRADEMARK ASSIGNMENT, DATED DECEMBER 14, 2017	ex10-3.htm	EX-10.3	24823
5	LICENSE AGREEMENT, DATED DECEMBER 14, 2017	ex10-4.htm	EX-10.4	89302
6	ESCROW AGREEMENT, DATED DECEMBER 14, 2017	ex10-5.htm	EX-10.5	95060
7	WARRANT, DATED DECEMBER 14, 2017	ex10-6.htm	EX-10.6	85957
	Complete submission text file	0001654954-17-011831.txt		583578

Mailing Address P.O. BOX 4960 TUALATIN OR 97062

Business Address P.O. BOX 4960 TUALATIN OR 97062 267-880-1595

QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)